MICHELLE CARO: Open Payments
NPI 1548039423 · DAYTONA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$277 in 12 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $838 · 2025 $277
Food & beverage: $277
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $39 |
| QOL Medical, LLC | 1 | $38 |
| Madrigal Pharmaceuticals | 1 | $33 |
| ABBVIE INC. | 2 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| GENZYME CORPORATION | 1 | $24 |
| Intercept Pharmaceuticals, Inc. | 1 | $24 |
| Braintree Laboratories, Inc. | 1 | $23 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $18 |
| AXOGEN | 1 | $17 |
Products named: DUPIXENT, TREMFYA, Sucraid, REZDIFFRA, OCALIVA, SUTAB, Linzess, CREON.
Industry payments across FL — which companies pay providers there.
